Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-23-055436

Head of Research & Development acquired 527 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Vig Pamela Head of Research & Development 2023-11-10 Grant or award +527 $22.29 $11,745 31,313 D
Loading xslF345X05/doc4.xml…